BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 29303020)

  • 1. Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.
    Zheng SH; Cao SJ; Xu H; Feng D; Wan LP; Wang GJ; Xiao XG
    Infect Dis (Lond); 2018 Jun; 50(6):443-451. PubMed ID: 29303020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo-β-Lactamase-1.
    Dong F; Zhang Y; Yao K; Lu J; Guo L; Lyu S; Yang Y; Wang Y; Zheng H; Song W; Liu G
    Microb Drug Resist; 2018 Mar; 24(2):154-160. PubMed ID: 28594635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.
    Liu C; Liu L; Jin MM; Hu YB; Cai X; Wan L; Zhang HY; Li RY; Wu XJ
    Curr Med Sci; 2022 Feb; 42(1):68-76. PubMed ID: 34985611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of tigecycline- and carbapenem-nonsusceptible Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline.
    Sheng ZK; Wang W; Guo Q; Xu X; Wang M; Yang Y; Wang M
    J Microbiol Immunol Infect; 2016 Dec; 49(6):962-968. PubMed ID: 26692183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
    Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
    J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
    Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
    J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
    Hussein K; Raz-Pasteur A; Finkelstein R; Neuberger A; Shachor-Meyouhas Y; Oren I; Kassis I
    J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak by Hypermucoviscous
    Zhan L; Wang S; Guo Y; Jin Y; Duan J; Hao Z; Lv J; Qi X; Hu L; Chen L; Kreiswirth BN; Zhang R; Pan J; Wang L; Yu F
    Front Cell Infect Microbiol; 2017; 7():182. PubMed ID: 28560183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole genome sequencing for the molecular characterization of carbapenem-resistant Klebsiella pneumoniae strains isolated at the Italian ASST Fatebenefratelli Sacco Hospital, 2012-2014.
    Rimoldi SG; Gentile B; Pagani C; Di Gregorio A; Anselmo A; Palozzi AM; Fortunato A; Pittiglio V; Ridolfo AL; Gismondo MR; Rizzardini G; Lista F
    BMC Infect Dis; 2017 Oct; 17(1):666. PubMed ID: 29017452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiological characterisation of Klebsiella pneumoniae isolates causing bloodstream infections from five tertiary hospitals in Beijing, China.
    Ma Y; Bao C; Liu J; Hao X; Cao J; Ye L; Yang J
    J Glob Antimicrob Resist; 2018 Mar; 12():162-166. PubMed ID: 29032055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.
    Menekşe Ş; Çağ Y; Işık ME; Şahin S; Hacıseyitoğlu D; Can F; Ergonul O
    Int J Infect Dis; 2019 Sep; 86():208-211. PubMed ID: 31402295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital.
    Cubero M; Cuervo G; Dominguez MÁ; Tubau F; Martí S; Sevillano E; Gallego L; Ayats J; Peña C; Pujol M; Liñares J; Ardanuy C
    BMC Microbiol; 2015 Sep; 15():177. PubMed ID: 26335352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.
    Papadimitriou-Olivgeris M; Marangos M; Christofidou M; Fligou F; Bartzavali C; Panteli ES; Vamvakopoulou S; Filos KS; Anastassiou ED
    Scand J Infect Dis; 2014 Sep; 46(9):642-8. PubMed ID: 25017796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream isolates at a Taiwanese hospital: clinical impacts of lowered breakpoints for carbapenems.
    Lee NY; Wu JJ; Lin SH; Ko WC; Tsai LH; Yan JJ
    Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1941-50. PubMed ID: 22249422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections.
    Li J; Ren J; Wang W; Wang G; Gu G; Wu X; Wang Y; Huang M; Li J
    Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):679-689. PubMed ID: 29238932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of metallo-β-lactamase among carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China.
    Li B; Xu XH; Zhao ZC; Wang MH; Cao YP
    Can J Microbiol; 2014 Oct; 60(10):691-5. PubMed ID: 25285938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.
    Borer A; Saidel-Odes L; Riesenberg K; Eskira S; Peled N; Nativ R; Schlaeffer F; Sherf M
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):972-6. PubMed ID: 19712030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug Resistance Mechanisms of Carbapenem Resistant Klebsiella pneumoniae Strains Isolated in Chongqing, China.
    Yan J; Pu S; Jia X; Xu X; Yang S; Shi J; Sun S; Zhang L
    Ann Lab Med; 2017 Sep; 37(5):398-407. PubMed ID: 28643488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.
    Nadkarni AS; Schliep T; Khan L; Zeana CB
    Am J Infect Control; 2009 Mar; 37(2):121-6. PubMed ID: 19249638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.